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tures in the progressive interstitial fibrosis in chronic rejection,Persistent rejection of peritubular capillaries and tubules is
and are probably key events in its pathogenesis.associated with progressive interstitial fibrosis.
Background. We have reported that a 12-day course of high
dose cyclosporine A treatment in thymectomized miniature
swine with major histocompatibility complex (MHC) class I-mis-
The leading cause of late kidney allograft failure ismatched renal allografts results in transient acute rejection
chronic rejection [1–3], yet little is known about its patho-followed by either in chronic rejection (progression group) or
graft acceptance (recovery group). Here, we examined the genesis. Chronic rejection is clinically characterized by
differential features between both groups in the peritubular a slow progressive deterioration in renal function, in-
capillaries (PTCs) and tubules to clarify the pathogenesis of creasing proteinuria and hypertension, commencing three
the progressive interstitial fibrosis in chronic rejection.
to six months after transplantation [1–3]. Pathologically,Methods. Morphometric and immunohistochemical studies
chronic rejection is characterized by progressive intersti-were performed on serial renal biopsies (days 0 to 100) ob-
tained from both groups, focusing on the cellular infiltrate, tial fibrosis, tubular atrophy, chronic allograft glomerulo-
rejection of PTCs and tubules, myofibroblast accumulation, pathy, chronic allograft arteriopathy, and modest inter-
and progressive interstitial fibrosis. stitial mononuclear cell infiltration [4]. Extensive work
Results. In the progression group, acute rejection occurred
by many groups has established that the degree of inter-by day 8 and progressed to chronic rejection by day 100,
stitial inflammation and fibrosis in renal disease corre-with the development of interstitial fibrosis. PTC endothelial
cell and tubular epithelial cell death associated with CD3 lates well with renal function and predicts the risk for
cell infiltration was evident, confirmed by nick end-labeling progression [5–8]. Although interstitial fibrosis is a com-
(TUNEL), commencing by day 8 and continuing thereafter. In mon finding in chronic rejection, its pathogenesis hasacute rejection, destruction of PTCs and tubules accompanied
not been fully investigated.by disruption of basement membrane (BM) occurred with
We have previously reported that inbred miniaturecapillaritis or tubulitis in areas with a severe cellular infiltrate.
During the development of chronic rejection, capillaritis of swine treated for 12 days with high dose cyclosporine
PTCs and tubulitis continued by day 100, accompanied by A (CsA) develop tolerance to major histocompatibility
persistent T cell infiltration, and the remaining PTCs and tu-
complex (MHC) class II-matched, class I-mismatchedbules exhibited progressive atrophy with thickening and/or
renal allografts [9]. The thymus is necessary for the in-lamination of BM. On day 100, identifiable PTCs and tubules
were lost in areas of interstitial fibrosis. Proliferating (PCNA) duction of a rapid and stable tolerance, presumably due
-actin myofibroblasts accumulated around PTCs, tubules to central selection mechanisms. When the protocol is
and in interstitium, and widespread interstitial fibrosis devel- modified by adding thymectomy 21 to 42 days prior tooped by day 100. In contrast, in the recovery group, injured
transplantation, only peripheral mechanisms of toler-PTCs and tubules recovered by day 100 based on the resolution
ance can operate. These thymectomized pigs developof acute rejection, and minimal loss of PTCs and tubules was
evident by day 100 with minimal interstitial fibrosis. acute vascular rejection (type II) at days 8 to 30 [10, 11].
Conclusions. Persistent rejection directed at PTCs and tu- Thereafter, in half of these animals, chronic rejection
bules, and proliferation of myofibroblasts are prominent fea-
develops with graft dysfunction by day 100 [12]. The
remaining animals recover from acute rejection and de-
velop transplant tolerance. The mechanism underlyingKey words: acute rejection, organ rejection, interstitial fibrosis, peritu-
bular capillary, tubular basement membrane, tubulitis. the diverse course of the two groups in the same experi-
mental protocol may depend on the effect of peripheral
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is believed to mediate chronic rejection, since circulating thenamine (PAM) stains were performed. To detect
CD3 T cells in interstitium and tubules, a standarddonor-reactive cytotoxic T-lymphocyte (CTL) and anti-
avidin-biotin-peroxidase complex (ABC) technique [13]donor class I immunoglobulin G (IgG) were detected in
was performed, using anti-human CD3 polyclonal anti-these animals [10–12]. This well-defined model provides
body (Dako, Glostrup, Denmark). This antibody was con-a novel opportunity to study the detail of chronic rejec-
firmed to react with swine pan T cells using swine thymus,tion, uncomplicated by drug effects, recurrent disease,
lymph nodes, and spleen. Activated fibroblasts (myo-or viral infection.
fibroblasts) were identified by expression of -smoothTo elucidate the pathogenesis of progressive intersti-
muscle actin [14–17], and were stained with the ABCtial fibrosis in chronic rejection, we compared serial graft
technique using anti-human -smooth muscle actin anti-biopsies obtained from the progression and recovery
body (Dako). Proliferating cells were identified by ex-groups, focusing on CD3 cell infiltration, rejection of
pression of proliferating cell nuclear antigen (PCNA).peritubular capillaries (PTCs) and tubules, accumula-
To optimize detection of PCNA, microwave treatmenttion, activation and/or proliferation of interstitial myofi-
(heating for 2  5 minutes in 0.01 mol/L sodium citratebroblasts, and subsequent interstitial fibrosis.
(pH 6.0) in a 750-watt microwave oven at full power and
then immediately chilling to 4C) and a 1/1000 dilution
METHODS of PC10 (Dako) was used [18]. Double immunostaining
with PCNA and -actin was performed using the two-Animals, surgery and immunosuppression
color staining technique [13]. Initially the sections wereTransplant donors and recipients were selected from
stained with PC10, and incubated with alkaline phospha-our herd of inbred Massachusetts General Hospital
tase-labeled anti-mouse IgG (Vector Laboratories, Bur-(MGH) miniature swine at five to seven months of age.
lingame, CA, USA) with a blue reaction product (Alka-Recombinant swine lymphocyte antigen (SLA)gg (class
line Phosphatase Substrate Kit III; Vector Laboratories).Ic/c, class IId/d) animals were donors, and SLAdd (class Id/d,
After denaturation of bound antibody molecules usedclass IId/d) animals were recipients of orthotopic kidney
in the first staining [19], sections were stained with anti-grafts, in order to achieve transplantation of SLA class
-actin antibody, biotin-labeled anti-mouse antibodyII-matched, class I-mismatched kidneys [9–11]. In all ani-
(Dako), ABC and visualized using hydrogen peroxidemals, a complete (N  6) or partial (N 2) thymectomy
(H2O2) containing 3,3-diaminobendizine (DAB; brownwas performed 21 to 42 days before kidney transplanta-
reaction product; Research Genetics, Hansville, AL,tion [10, 11]. CsA was provided by Novartis Pharmaceuti-
USA). Negative controls involved omission of the pri-cal Corp. (Hanover, NJ, USA) and was administered
mary antibody or substitution with an irrelevant anti-
daily as a single infusion at a dose of 10 to 13 mg/kg body.
(adjusted to maintain a blood level of 400 to 800 ng/mL) In histological sections, fragmented nuclear DNA associ-
for 12 consecutive days, starting on the day of kidney ated with apoptosis and sometimes necrosis was labeled
transplantation. Based on the results of our previous by the terminal deoxynucleotidyl transferase (TdT)-medi-
study [12], eight thymectomized animals were divided ated dUTP-biotin nick end-labeling (TUNEL) method
into two groups: the progression group (N  4; 3 com- [20]. The sections were incubated with proteinase K,
plete and one partial thymectomy), which progressed to rinsed in TdT buffer, and incubated with TdT 1:25 and
chronic rejection by day 100, and the recovery group biotinylated-dUTP 1:20 in TdT buffer for 60 minutes at
(N  4; 3 complete and one partial thymectomy), which 37C. The biotinylated nuclei were detected with avidin-
was characterized by recovery from acute rejection with peroxidase, and H2O2 containing DAB. Double staining
development of transplant tolerance by day 100. Analysis with TUNEL and CD3 was performed by immuno-alka-
of our data showed no differences with regard to the line phosphatase using the TUNEL method, followed
clinical background, including serum levels of CsA, by 0.1% avidin and 0.01% biotin, an antibody to CD3,
aging, viral infection, blood pressure and proteinuria in and the ABC technique with H2O2 containing DAB.
the early phase after transplantation between partial and Controls involved omission of antibody and omission of
complete thymectomy groups or between the progres- the dUTP or TdT in TUNEL procedures.
sion and recovery groups. In each group, sequential For electron microscopic studies, the kidney tissue
wedge kidney biopsies were performed on postoperative was fixed in 2.5% glutaraldehyde solution in phosphate
days 0, 8, 18, 30, 60, and 100. buffer (pH 7.4) and postfixed with 1% osmium tetroxide,
dehydrated, and embedded in Epon 812. Ultrathin sec-
Histological examination tions were stained with lead citrate.
For light microscopic examination, tissue was fixed
Quantification of histological findingsin 10% buffered formalin and embedded in paraffin.
Hematoxylin and eosin (H&E), periodic acid-Schiff Morphometric studies were performed sequentially
for the following: (1) the number of CD3 cells in peritu-(PAS), Masson Trichrome and periodic acid silver me-
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bular interstitium (both intracapillary and interstitial creased rapidly and -actin interstitial areas also re-
duced in size in association with resolution of acute rejec-compartments combined) or in tubules per mm2; (2) the
number of TUNEL damaged endothelial cells in PTCs tion by day 60 (Figs. 2 G, H, and 3), with a resultant
minimal interstitial fibrosis (Fig. 1 D–F).and tubular epithelial cells per mm2; (3) the percentage
of tubules with tubulitis (CD3-stained sections), dis-
PTC and tubular injury in progressiverupted tubular basement membrane (TBM) (PAM-stained
interstitial fibrosissections), and atrophy (PAS-stained sections), and (4)
the number of -actin/PCNA proliferating myofi- In both the progression and recovery groups, acute
rejection occurred on days 8 to 30, and CD3 T cells in-broblasts in tubulointerstitium per mm2. We identified
the cell type of TUNEL cells by its location, morpho- filtrated into the peritubular interstitium (in and around
capillaries) and tubules (Fig. 4A). In the progressionlogic appearance and CD3 expression; those in which
the cell type could not be determined were excluded group, numerous CD3 cells infiltrated by day 100 along
with the development of chronic rejection (Fig. 4B). In(5% or less). Forty fields of renal cortex were counted
in all biopsy specimens, without prior knowledge of the contrast, in the recovery group, the T cell infiltrate in
peritubular interstitium and tubules diminished rapidlyclinical or histologic diagnosis, at 400, using an optical
grid of area 0.0625 mm2. Counts were expressed as the by day 60 (Fig. 4 C, D), in association with resolution
of the acute rejection.number of positive cells per mm2 or the % tubules af-
fected. In addition, for evaluation of (5) -actin inter- During acute rejection in both groups, TUNEL cells
in PTCs and tubules appeared on days 8 to 18 (Fig. 5).stitial areas and (6) interstitial fibrosis, each grid area
(400) was graded semiquantitatively on specimens with Most TUNEL cells did not express CD3, indicating
that majority of TUNEL cells were not of T cell origin-actin stain or Masson Trichrome stain using a graded
system [21, 22]: grade 0  normal interstitium and tu- and may be PTC endothelial or tubular epithelial cells.
In the progression group, prominent TUNEL cells inbules; grade 1  mild -actin or Masson Trichrome
PTCs and tubules were evident with persistent cell infil-(fibrosis) with minimal interstitial thickening between
trate by day 60 and thereafter (Figs. 5 and 6). In contrast,tubules; grade 2  moderate -actin or fibrosis with
in the recovery group these acutely damaged cells hadmoderate interstitial thickening between tubules; grade
diminished in number by day 60 (Figs. 5 and 6). The3  severe -actin or fibrosis with severe interstitial
numbers of TUNEL cells in PTCs and tubules werethickening between tubules. Counts were expressed as
significantly higher in the progression group than in thestaining grade per grid area. These results were ex-
recovery group between day 30 and day 100.pressed as mean  standard error of the mean (SEM),
and statistical analysis was performed using the unpaired
Peritubular capillariesStudent t test.
During acute rejection in both groups, the PTCs ini-
tially exhibited accumulation of intraluminal mononu-
RESULTS clear cells on day 8 (Fig. 7A). In areas with severe cell
In the progression group, progressive interstitial fi- infiltration, destruction of PTCs occurred with disruption
brosis was noted, together with progressive chronic allo- of the basement membrane (BM; Fig. 8A). The re-
graft glomerulopathy and arteriopathy, in association maining PTCs had small capillary lumina with activated
with the development of chronic rejection and graft dys- endothelial cells, and became separated from tubules
function (Fig. 1 A–C). Prior to the development of inter- by interstitial cells and/or edema on day 18 (Fig. 7B).
stitial fibrosis, -actin myofibroblasts accumulated in Ultrastructurally, activated endothelial cells were char-
the interstitium by day 18 and were prominent between acterized by cell hypertrophy and loss of fenestrae (Fig.
days 30 and 60 (Fig. 2 A–C). Many -actin cells also 8B). In the progression group, endothelial activation
contained PCNA nuclei (Fig. 2 E, F), indicating that continued thereafter, with mononuclear cell infiltrate
many interstitial myofibroblasts were proliferating in the and duplication of the capillary BM on days 30 to 60
interstitium on days 18 to 30. Thereafter, along with the (Figs. 7C and 8C). The reduced size of PTCs remained
development of interstitial fibrosis, PCNA/-actin on day 100 with narrowed lumina and lamination of BM
proliferating myofibroblasts gradually decreased with (Figs. 7D and 8 D, E). Some PTCs were lost in areas
the reduction of -actin interstitial areas in size by day of fibrosis (Fig. 8F). Interstitial -actin myofibroblasts
100 (Figs. 2D and 3). A significant number of proliferat- initially accumulated around PTCs by day 18 and pro-
ing myofibroblasts and the degree of -actin interstitial gressed into the interstitium between PTCs and tubules
areas were evident during development of fibrosis in the by day 30 and thereafter (Fig. 7 E, F). Electron micros-
progression group compared with in the recovery group copy revealed that myofibroblasts accumulated and en-
(Fig. 3). In contrast, in the recovery group, the number compassed the PTCs in a fashion similar to smooth mus-
cle cells in arterioles (Fig. 8 B–D). In the recovery group,of PCNA/-actin proliferating myofibroblasts de-
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Fig. 1. Interstitial fibrosis in the progression
(A-C) and recovery groups (D-F) on days 30
(A, D), 60 (B, E), and 100 (C, F). In associa-
tion with development of chronic rejection,
progressive interstitial fibrosis occurs in the
progression group. Chronic allograft glomeru-
lopathy (arrowhead) and arteriopathy (arrow)
developed by day 100. In contrast, only mild
interstitial fibrosis remains after acute rejec-
tion in the recovery group. Masson Trichrome
stain, 250.
Fig. 5. TUNEL injured PTC endothelial
cells (A-D) and tubular epithelial cells (E-H)
in the progression (A, B, E, F) and recovery
(C, D, G, H) groups on days 18 (A, C, E, G)
and 60 (B, D, F, H). In both groups, many
TUNEL damaged PTC endothelial cells and
tubular epithelial cells (arrow) are seen with
CD3 T cell infiltrates in the early phase.
These damaged cells are in contact with the
CD3 infiltrating T cells. In the progression
group, numerous damaged cells remain by day
60, whereas these cells progressively diminish
by day 60 in the recovery group. A-H: TUNEL
(black) and CD3 (brown) double stain, 800.
Fig. 2. Interstitial myofibroblast accumulation in the progression (A-F) and recovery (G, H) groups. In pretransplant controls (A), a small number
of -actin cells are seen in the interstitium; the media of arterioles is also -actin. During progression of chronic rejection, -actin interstitial
myofibroblasts progressively accumulate on days 30 (B) and 60 (C). Subsequently, by day 100 (D), -actin cells gradually reduce with the
development of interstitial fibrosis. -Actin mesangial or smooth muscle cells are seen in the glomeruli or small arteries during the development
of chronic allograft glomerulopathy (arrowhead) or arteriopathy (arrow). Both -actin and PCNA proliferating myofibroblasts (arrow) are
present around PTCs and tubules on days 18 (E) and 30 (F). In the recovery group, although -actin myofibroblasts accumulate on days 30 (G),
these cells reduce rapidly and only a few remain by day 100 (H). A-D, G, H: -actin stain, 250; E, F: double stain with -actin (brown) and
PCNA (black), 600.
Fig. 4. CD3 T cell infiltrate in the progression (A, B) and recovery (C, D) groups on days 18 (A, C) and 60 (B, D). Many CD3 cells are seen
in the early phase in both groups. Thereafter, the CD3 cell infiltrate persists in the progression group. In contrast, in the recovery group,
progressively diminishing T cell infiltrate is evident by day 60. CD3 stain; A, B 400; C, D 250.
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Fig. 3. Morphometric analysis of the number of proliferating myofibroblasts (PCNA/-actin cells) (A), the degree of -actin interstitial area
(score: 0-3) (B), and the degree of interstitial fibrosis (score: 0-3) (C ) in the progression () and the recovery () groups. Preceding the development
of interstitial fibrosis in the progression group, -actin/PCNA cells, and -actin interstitial areas are significantly more prominent than in
the recovery group. Values are expressed as mean  SEM, *P  0.05, **P  0.01, ***P  0.001.
Fig. 6. Morphometric analysis of the CD3
T cell infiltrate (A, C), and TUNEL cells
(B, D) in PTCs (A, B) and tubules (C, D) in
the progression () and recovery () groups.
CD3 T cell infiltrates and the numbers of
TUNEL cells in PTCs and tubules are sig-
nificantly higher in the progression group than
in the recovery group during development of
interstitial fibrosis. Values are expressed as
mean  SEM, *P  0.05, **P  0.01, ***P 
0.001.
acute PTC damage was noted during acute rejection on Tubules
day 18 (Fig. 7G), as in the progression group. However, During acute rejection in both groups, on days 8 to
less marked endothelial activation was observed on days 18, numerous CD3 cells infiltrated into tubules and
18 to 30 (Fig. 8G), and endothelial changes resolved with caused tubulitis (Fig. 9A). Tubules with extensive cell
minimal capillary loss or duplicated BM by day 100 (Figs. infiltrate were accompanied by prominent destruction of
TBM (Figs. 9B and 10). In the progression group, tubu-7H and 8H).
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Fig. 7. Peritubular capillary (PTC) injury (A-D, G, H) and -actin interstitial myofibroblasts (E, F) in the progression (A-F) and recovery (G,
H) groups on days 8 (A), 18 (B, E, G), 30 (F), 60 (C), and 100 (D, H). Mononuclear cell accumulation in PTCs (arrow) precedes interstitial
inflammation on day 8 (A); injured PTCs (arrow) are separated from tubules by interstitial edema and/or cells on day 18 (B). These PTC alterations
continue with duplication of BM (arrow) by day 60 (C), and finally, narrowed PTCs remain with thickened and duplicated BM (arrow) on day
100 (D). Initially, -actin cells accumulate around injured PTCs on day 18 (E), and progressed into the interstitium between PTCs and tubules
by day 30 (F). In the recovery group, damaged PTCs (arrow) with mononuclear cell infiltrates are found on day 18 (G); however, the mononuclear
cell infiltrate resolves by day 100 with minimal capillary loss and duplicated BM (H). A-D, G, H: PAM stain; A, B, G: 600, C, D, H, 800; E,
F: -actin stain, 600.
litis and destroyed TBM were evident by day 100 (Fig. DISCUSSION
9 C, D). Surrounding tubules with severe tubulitis, espe- The severity of tubulointerstitial injury in renal disease
cially those with disrupted TBM, many -actin intersti- is considered as an important determinant of progressive
tial myofibroblasts accumulated, and these cells also deterioration of renal function [5–8]. In chronic rejec-
were detected within damaged tubules (Fig. 9 E, F). In tion, few studies have been performed to characterize
areas of severe interstitial inflammation, loss of tubular tubulointerstitial injury and fibrosis. In our large animal
structure was evident with accumulation of-actin cells model, chronic rejection was characterized by progres-
(Fig. 9 C, G). Many -actin cells also accumulated sive interstitial fibrosis, accompanied by progressive allo-
around atrophic tubules (Fig. 9H). The frequency of graft glomerulopathy and arteriopathy. During the de-
tubules exhibiting tubulitis, disrupted TBM, and atrophy velopment of interstitial fibrosis, injured PTCs and
in the progression group was significantly higher than in tubules were characterized by the presence of dead PTC
the recovery group during the development of interstitial endothelial and tubular epithelial cells, destruction of
their structure with fragmented BM and/or progressivefibrosis (Fig. 11).
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Fig. 8. Electron microscopy reveals PTC alterations in the progression (A-F) and recovery (G, H) groups on days 18 (A), 30 (B, G), 60 (C), and
100 (D-F, H). (A) Destruction of PTCs (→) occurs with disruption of BM during acute rejection (2000). (B) The remaining PTCs have activated→
endothelial cells. Myofibroblasts separate the PTCs from tubules and encompass the PTCs as smooth muscle cells do in arterioles (arteriolization
of capillaries; 2500). These PTC alterations continue until day 60 (C; 2500), and the decreased size of PTCs persist on day 100 (D; 3400)
with lamination of BM (←) (E; 2500). A dense collagen matrix accumulates between PTCs and tubules. (F) Loss of PTCs is evident around
tubules (*) with interstitial fibrosis (1000). In the recovery group, less marked PTC alterations are evident at day 30 (G; 2000), and resolve by
day 100 (H; 2000).
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Fig. 9. Tubules with tubulitis, disrupted tubular basement membrane (TBM) and atrophy and -actin myofibroblasts in the progression group.
Severe tubulitis is characterized by prominent CD3 cell infiltrate in the tubules on day 30 (A; CD3 stain, 600), and is often accompanied by
disrupted TBM (B; PAM stain, 600). On days 18 (C) to 100 (D), loss of identifiable tubular structure is evident with interstitial inflammation
and/or fibrosis (PAM stain, 300). Tubules with tubulitis and disrupted BM (*) and atrophic tubules (arrowhead) are evident. Surrounding areas
of severe tubulitis, many -actin cells accumulate, and some of these cells (←) are present inside the damaged tubules on days 30 (E) and 60
(F ), suggesting that the damaged tubules being incorporated into the fibrosis (-actin stain, 600). In areas of interstitial inflammation, loss of
identifiable tubules (G) and tubular atrophy (H) are accompanied by many -actin myofibroblasts on day 60 (-actin stain, 250).
atrophy with thickened BM, accompanied by myofi- The vasculature of a grafted organ is the primary tissue
component that encounters the recipient’s immune sys-broblast accumulation. Cellular and humoral immunity
may be associated with PTC endothelial and tubular tem. Graft endothelium including PTC endothelium in
pigs and humans expresses the MHC class I and II anti-epithelial cell injury, since these animals persistently har-
bor donor reactive cytotoxic T lymphocyte (CTL) and gens in the resting phase. Moreover, activated endothe-
lial cells enhance the expression of MHC and adhesionantidonor MHC class I IgG in the peripheral circulation
[11, 12]. Ultimately, loss of identifiable PTCs and tubules molecules on their surface [23–26], thus becoming targets
for infiltrating alloreactive cytotoxic cells and circulatingwas evident in fibrotic areas. These pathologic features
in this model are due to specific anti-donor immune antidonor MHC class I or II antibodies. In arteries, rejec-
tion of endothelial cells is characterized by endotheli-responses, uncomplicated by drug effects, recurrent dis-
ease or viral infection. Our findings in the present study alitis, endarteritis or necrotizing arteritis during acute
rejection [4]. The present study demonstrates the exis-suggest that persistent immune-mediated rejection di-
rected at PTC endothelium and tubular epithelial cells tence of TUNEL dead cells in PTCs associated with
increased numbers of infiltrating T cells during acutecontributes to progressive interstitial fibrosis in chronic
rejection, and is probably a crucial event in its pathogen- rejection. PTC destruction also was evident in associa-
tion with cell infiltrates. These findings indicate that theesis.
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Fig. 10. Electron microscopy reveals disruption of the TBM in a severe tubulitis lesion. (A) The TBM is indicated by the arrows (↓). Between
the arrows the TBM associated with a mononuclear cell infiltrate is not detected (4300). (B) Exploded view from the section indicated by the
arrowhead in panel A. A mononuclear cell migrates through TBM from the interstitium into the tubule with destruction of the TBM. The arrows
also indicate that the TBM destruction is associated with a mononuclear cell infiltrate (8700).
Fig. 11. Frequency of tubules with tubulitis (A), disrupted TBM (B), and atrophy (C) in the progression () and the recovery () groups. The
frequency of tubules with tubulitis, disrupted TBM, or atrophy in the progression group is significantly higher than in the recovery group during
development of interstitial fibrosis. Values are expressed as mean  SEM, *P  0.05, **P  0.01, ***P  0.001.
interstitial infiltrate is actually focused on the PTCs, may contribute to PTC injury. In the grafts, however,
only minimal deposition of IgM and IgG was noted onwhose endothelium represents an important target of the
immune response. Injured PTCs exhibited progressively PTCs (data not shown). Deposits of IgG and IgM were
evident in the small arteries and glomeruli. These find-decreased size with narrowing of the lumina and multi-
layering of the BM. During development of chronic re- ings, which are characterized by no specific or distinct
reactivity for immunoglobulin (IgG, IgM, IgA) and C3jection, TUNEL dead cells in PTCs were prominent
even on day 100. TUNEL cells indicate an ongoing on PTCs, even in cases with humoral rejection, are well
defined in clinical renal transplantation [27, 28]. Re-lethal cell injury (apoptosis) and that the apoptotic cells
are quickly removed by phagocytic cells. Our results cently, we reported that C4d on PTCs is a useful diagnos-
tic marker of acute and chronic humoral rejection, andindicate that acute immunologic injury to PTCs persists
during chronic rejection and may contribute to progres- that C4d was detected on PTCs in such cases, although
no IgG, IgM, IgA and C3 were identified on PTCs [27,sive interstitial fibrosis. Since animals in the progression
group in this model have anti-donor MHC class I anti- 28]. We are interested in identifying evidence of hu-
moral-mediated rejection of PTCs in our animal model,body in their circulation [11, 12], humoral immunity also
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terized by obstructive arteriopathy, was evident in theand currently are searching for an antibody that can
progression group (percentage of arteries with obstruc-detect pig C4d or a new technique that can examine pig
tive changes on day 100; 6.8  0.6% in the progressionimmunoglobulin and complement deposition on PTCs.
group vs. 0.5  0.2% in the recovery group, mean Following PTC injury, endothelial cells became acti-
SEM; P  0.001). In the glomeruli, progressive allograftvated and were characterized by cell hypertrophy and
glomerulopathy was noted in the progression grouploss of fenestrae, resembling endothelium in high endo-
(Shimizu et al, manuscript in preparation). Chronic allo-thelial (also referred to as postcapillary) venules [29–31].
graft arteriopathy and glomerulopathy plus narrowingSince high endothelial venules in lymphoid tissue are
or loss of PTCs probably contributed to tubular atrophy,the entry site for leukocytes into the lymph node [32, 33],
associated with ischemic tubular as well as interstitialthese changes in PTC endothelium may enhance the
injury. Severe and/or persistent inflammation in tubulesinflux of inflammatory cells into renal allografts and me-
(tubulitis) also may mediate tubular injury. In addition,diate more severe rejection. Interestingly, it has been
damaged tubular epithelial cells are involved in the de-demonstrated that the only site of entry of leukocytes
velopment of interstitial fibrosis, as proinflammatory ef-into rejecting renal allografts is via PTCs [29, 30].
fector cells, through the increase expression of antigen-Ultrastructurally, injured PTCs also are characterized
presentation molecules and release of several cytokinesby separation from tubules by accumulated myofibro-
and growth factors [41, 42].blasts that encompass the PTCs. Since this structure
Activated fibroblasts have been demonstrated to changeresembles that of arterioles, we have termed it “arterioli-
their phenotype, and transform into “myofibroblasts,”zation of capillaries.” Mesangial interposition in glomer-
characterized by expression of -smooth muscle actin
uli, which is often evident in several glomerulonephritis [14–17, 41, 43]. Transforming growth factor-	 and
and transplant glomerulopathies, is also characterized by PDGF-BB can induce the myofibroblast phenotype in
-actin mesenchymal cells (activated mesangial cells) resting fibroblasts [42, 44]. Myofibroblasts are associated
encompassing the injured glomerular capillaries [4, 34], with increased extracellular matrix synthesis and pro-
and this structure may also equate with arteriolization mote progressive interstitial fibrosis. In human renal allo-
of capillaries. In this model, mesangial interposition is grafts, myofibroblasts are associated with progressive in-
prominent in acute and chronic allograft glomerulopathy terstitial fibrosis and chronic rejection [15–17]. The
that is induced by persistent T cell- and antibody-medi- present study also demonstrated both proliferative and
ated glomerular capillary injury (Shimizu et al; manu- phenotypic changes of interstitial fibroblasts from the
script in preparation). These findings suggest that arte- early phase of rejection, and these changes were promi-
riolization of capillaries may be a common reaction of nent during progressive interstitial fibrosis. Interestingly,
capillaries after and/or during severe and persistent im- the first -actin and/or PCNA myofibroblasts recog-
mune-mediated endothelial injury in microvasculature, nized were in circumfluent areas around PTCs in acute
and it is possible that the myofibroblasts can constrict rejection. These results suggest that fibrocytes initially
the capillary to cause functional stenosis to blood flow activate, accumulate and proliferate around PTCs, may
and mediate more severe interstitial injury. react to immune-mediated PTC damage, and enhance
Recent studies have demonstrated the splitting and subsequent progressive interstitial fibrosis. Consistent
multilayered duplication of the PTC BM in chronic rejec- with this finding, electron microscopy revealed that myo-
tion [35, 36]. Both cellular and humoral immunity are fibroblasts encompassed injured PTCs resulting in “arte-
known to induce multilayering of the PTC BM in chronic riolization” of capillaries.
rejection [28, 37]. In our study, persistent immunologic Accumulation of proliferative myofibroblasts was
endothelial cell injury was associated with decreased prominent around tubules with severe tubulitis and dis-
rupted TBM. Curiously, -actin cells also were ob-PTC size with lamination of BM. Since regenerated en-
served within damaged tubules. Recent studies suggestdothelial cells produce a new BM layer [38], such multi-
that tubular epithelial cells can transdifferentiate intolayering of the BM could be the result of persistent
fibroblasts [45, 46]. Although it was not clear in thisimmunologic injury and subsequent activation of endo-
study whether -actin cells in tubules were of tubularthelial cells.
epithelial or migrating fibroblast origin, it is possible thatDuring development of chronic rejection in the pres-
intratubule -actin cells mediate ectopic fibrosis in theent study, progressive tubular atrophy and loss of identi-
tubules, and the disrupted tubules may be incorporatedfiable tubules occurred with progressive interstitial fi-
into the fibrosis.brosis. Frequent tubules with tubulitis and/or fractured
In conclusion, chronic rejection is characterized patho-TBM were evident with accumulation and proliferation
logically by progressive interstitial fibrosis, tubular atro-of myofibroblasts. The progressive tubular atrophy and
phy, chronic allograft arteriopathy, chronic allograftloss of tubules may have been induced by multiple pri-
glomerulopathy and modest mononuclear cell infiltra-mary and/or secondary mechanisms [39–41]. In the pres-
ent study, chronic allograft arteriopathy, which is charac- tion in the interstitium. In this regard, arteriopathy and
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during the progression of experimental glomerulonephritis in rat.glomerulopathy are considered as important events in
J Am Soc Nephrol 11:47–56, 2000
the development of interstitial fibrosis. Furthermore, we 9. Rosengard BR, Ojikutu CA, Guzzetta PC, et al: Induction of
specific tolerance to class I-disparate renal allografts in miniaturehave demonstrated in the present study that persistent
swine with cyclosporin. Transplantation 54:490–497, 1992immune-mediated rejection directed at PTCs and tu-
10. Yamada K, Gianello PR, Ierino FL, et al: Role of the thymus
bules is associated with proliferation of interstitial myo- in transplantation tolerance in miniature swine. I. Requirement of
the thymus for rapid and stable induction of tolerance to class I-fibroblasts and progressive interstitial fibrosis in chronic
mismatched renal allografts. J Exp Med 186:497–506, 1997rejection, and thus may play an essential role in its patho-
11. Yamada K, Ierino FL, Gianello PR, et al: Role of the thymus
genesis. A better understanding of immune-mediated in transplantation tolerance in miniature swine. III. Surgical manip-
ulation of the thymus interferes with stable induction of tolerancerejection of PTCs and tubules and the subsequent cellu-
to class I mismatched renal allografts. Transplantation 67:1112–lar and biochemical networks of progressive interstitial
1119, 1999
fibrogenesis, including roles of myofibroblasts and the 12. Shimizu A, Yamada K, Sachs DH, Colvin RB: Intragraft events
preceding chronic renal allograft rejection in a modified toleranceinflammatory cytokine network, may facilitate the design
protocol. Kidney Int 58:2546–2558, 2000of new therapies to reduce interstitial fibrosis, graft dys-
13. Shimizu A, Yamada K, Meehan SM, et al: The acceptance reaction:
function, and graft loss in chronic rejection. Intragraft events associated with tolerance to renal allografts in
miniature swine. J Am Soc Nephrol 11:2371–2380, 2000
14. Gabbiani G: The biology of myofibroblasts. Kidney Int 41:530–532,ACKNOWLEDGMENTS 1992
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